SCHEMBL334287

SCHEMBL334287

CC(C)c1ccc(-n2c(CC(=O)O)c(C(=O)O)c3cc(Oc4ccc(Cl)c(Cl)c4)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.43
NPBWR1 P48145 1/20 0.41
MCHR1 Q99705 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
USP14 P54578 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HIF1A Q16665 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
GAA P10253 1/20 0.38
THRA P10827 2/20 0.38
THRB P10828 2/20 0.38
KMO O15229 1/20 0.37
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PPARG P37231 2/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL333959 0.91 USP14 (0.49) FFAR1MEN1KMT2AUSP14KDM4E
SCHEMBL334342 0.89 USP14 (0.45) FFAR1MEN1KMT2AUSP14KDM4E
SCHEMBL334235 0.88 BCL2 (0.42) MEN1KMT2AUSP14KDM4EGAA
SCHEMBL332701 0.87 MEN1 (0.38) FFAR1MEN1KMT2AUSP14KDM4E
SCHEMBL334171 0.86 PPARG (0.47) MEN1KMT2AUSP14PPARG
SCHEMBL1407175 0.85 PPARG (0.39) FFAR1MEN1KMT2AUSP14KDM4E
SCHEMBL332700 0.84 MEN1 (0.41) MEN1KMT2AUSP14KDM4EHIF1A
SCHEMBL333818 0.83 PPARG (0.52) PPARG
SCHEMBL332699 0.83 PPARG (0.38) FFAR1MEN1KMT2AUSP14KDM4E
SCHEMBL504142 0.82 MEN1 (0.44) FFAR1MEN1KMT2AUSP14PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097623-B2 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics BIOLIPOX AB (SE) 2012-01-17 US disclosed
EP-1841735-B1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2011-03-09 EP disclosed
US-20090076004-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076004-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, AREG FFAR1 2021/4885NPBWR1 891/4885MCHR1 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.